Breaking news and real-time updates from the ASX small-cap market
Clarity Pharmaceuticals hits SECuRE main-group recruitment target, advancing its prostate cancer therapy trial as Phase III planning gets underway.
Torque Metals secures $25m to accelerate drilling and resource growth at its Ritz gold project, lifting pro forma cash to $32.7m.
Rimfire Pacific Mining reports 15-week Murga scandium recoveries, with tests pointing to up to 60% saprolite extraction via lower-capital atmospheric leaching.
Australian Vanadium signs non-binding Tyfast MOU to assess vanadium oxide for heavy-duty lithium batteries, expanding beyond flow battery markets.
Fortuna Metals hits a Mkanda-record 3.43% rutile in maiden Mlongo drilling below its 298Mt resource, pointing to significant depth upside.
D3 Energy wins strategic project status as restored flow confirms 5.2% helium and five new permits expand its South African footprint.
Trajan Group opens FY27 with Q1 nEBITDA of $3.5m and expects double-digit earnings growth as cost savings drive momentum.
Renascor Resources produces 99.97%-pure battery-grade spherical graphite at its new South Australian demonstration plant, validating its HF-free process.
Axel REE advances Caladão toward first ISR field tests at Woolrich after column tests returned up to 560ppm soluble TREO.
Sea Forest signs Teys Australia distribution deal targeting SeaFeed adoption across 480,000 cattle, lifting its contracted reach to 541,000 head.
Dalaroo Metals hits 18m at 7.31g/t gold in maiden Bondoukou drilling, with broad mineralisation from surface.
EV Resources has rebranded as Antimony Resources and begun ASX trading as ANT, sharpening its focus on critical antimony projects in North America and Mexico.
